|
|
食管胃结合部癌淋巴结转移研究进展
|
Abstract:
近些年，食管胃结合部癌发病率呈现上升的趋势，对其病因学、生物学行为的研究越来越受到重视。食管胃结合部癌因其解剖学部位的特殊性及生物学行为的不同，其治疗及预后亦有不同。食管胃结合部癌淋巴结转移是影响患者预后的重要因素之一，因该处淋巴引流存在双向性，向头侧引流入下纵隔、甚至中纵隔及上纵隔的可能，向尾侧引流入腹腔胃周淋巴网络及腹腔干的方向。因此，研究食管胃结合部癌的淋巴引流路径及不同类型食管胃结合部癌淋巴结转移规律，将有助于改善此类患者的预后。本文综述了近些年关于食管胃结合部癌淋巴结转移相关研究及报道，以期为食管胃结合部癌的治疗提供参考。
In recent years, the incidence rate of cancer in the junction of the esophagus and stomach has been on the rise, and more and more attention has been paid to the study of its etiology and biological behavior. The treatment and prognosis of esophageal gastric junction cancer vary due to the unique anatomical location and different biological behaviors. Lymph node metastasis in esophageal and gastric junction cancer is one of the important factors affecting the prognosis of patients. Due to the bidirectional nature of lymphatic drainage in this area, there is a possibility of drainage into the lower mediastinum, even the middle and upper mediastinum, and towards the tail, into the direction of the abdominal perigastric lymph network and the abdominal trunk. Therefore, studying the lymphatic drainage pathways of esophagogastric junction cancer and the lymph node metastasis of different types of esophagogastric junction cancer will help improve the prognosis of such patients. This article reviews recent research and reports on lymph node metastasis in esophageal gastric junction cancer, intending to provide a reference for treating esophageal gastric junction cancer.
| [1] | Song, Y., Liu, X., Cheng, W., et al. (2022) The Global, Regional and National Burden of Stomach Cancer and Its Attributable Risk Factors from 1990 to 2019. Scientific Reports, 12, Article No. 11542. https://doi.org/10.1038/s41598-022-15839-7 |
| [2] | Zhao, X., Liu, X., Tang, P., et al. (2009) The Extent and Value of Lymphadenectomy in Treating Gastroesophageal Junction Carcinoma. The Chinese-German Journal of Clinical Oncology, 8, 438-442. https://doi.org/10.1007/s10330-009-0086-7 |
| [3] | Hosoda, K., Yamashita, K., Moriya, H., Mieno, H. and Watanabe, M. (2017) Optimal Treatment for Siewert Type II and III Adenocarcinoma of the Esophagogastric Junction: A Retrospective Cohort Study with Long-Term Follow-Up. World Journal of Gastroenterology, 23, 2723-2730. https://doi.org/10.3748/wjg.v23.i15.2723 |
| [4] | Huang, C.M. and Zheng, C.H. (2015) Laparoscopic Gastrectomy for Gastric Cancer. Springer, New York. https://doi.org/10.1007/978-94-017-9873-0 |
| [5] | Nishiwaki, N., Noma, K., Matsuda, T., et al. (2020) Risk Factor of Mediastinal Lymph Node Metastasis of Siewert Type I and II Esophagogastric Junction Carcinomas. Langenbeck’s Archives of Surgery, 405, 1101-1109. https://doi.org/10.1007/s00423-020-02017-4 |
| [6] | Chen, X.D., He, F.Q., Chen, M. and Zhao, F.Z. (2020) Incidence of Lymph Node Metastasis at Each Station in Siewert Types Ⅱ/Ⅲ Adenocarcinoma of the Esophagogastric Junction: A Systematic Review and Meta-Analysis. Surgical Oncology, 35, 62-70. https://doi.org/10.1016/j.suronc.2020.08.001 |
| [7] | Li, Z.L., Zhao, L.Y., Zhang, W.H., et al. (2022) Clinical Significance of Lower Perigastric Lymph Nodes Dissection in Siewert Type II/III Adenocarcinoma of Esophagogastric Junction: A Retrospective Propensity Score Matched Study. Langenbeck’s Archives of Surgery, 407, 985-998. https://doi.org/10.1007/s00423-021-02380-w |
| [8] | Liang, R., Bi, X., Fan, D., Du, Q., Wang, R. and Zhao, B. (2022) Mapping of Lymph Node Dissection Determined by the Epicenter Location and Tumor Extension for Esophagogastric Junction Carcinoma. Frontiers in Oncology, 12, Article 913960. https://doi.org/10.3389/fonc.2022.913960 |
| [9] | Kurokawa, Y., Takeuchi, H., Doki, Y., et al. (2021) Mapping of Lymph Node Metastasis from Esophagogastric Junction Tumors: A Prospective Nationwide Multicenter Study. Annals of Surgery, 274, 120-127. https://doi.org/10.1097/SLA.0000000000003499 |
| [10] | Yoshikawa, T., Takeuchi, H., Hasegawa, S., et al. (2016) Theoretical Therapeutic Impact of Lymph Node Dissection on Adenocarcinoma and Squamous Cell Carcinoma of the Esophagogastric Junction. Gastric Cancer, 19, 143-149. https://doi.org/10.1007/s10120-014-0439-y |
| [11] | Yabusaki, H., Nashimoto, A., Matsuki, A. and Aizawa, M. (2014) Comparison of the Surgical Treatment Strategies for Siewert Type II Squamous Cell Carcinoma in the Same Area as Esophagogastric Junction Carcinoma: Data from a Single Japanese High-Volume Cancer Center. Surgery Today, 44, 1522-1528. https://doi.org/10.1007/s00595-013-0773-4 |
| [12] | Zheng, Z., Zhang, H.Q., Xu, R., et al. (2020) Assessment of Risk Factors of Lymph Node Metastasis and Prognosis of Siewert II/III Adenocarcinoma of Esophagogastric Junction: A Retrospective Study. https://doi.org/10.21203/rs.2.23871/v1 |
| [13] | Shu, P., Sun, X., Liu, F., Fang, Y., Shen, K., Sun, Y., Qin, J. and Qin, X. (2021) Pattern of No. 12a Lymph Node Metastasis in Gastric Cancer. Chinese Journal of Cancer Research, 33, 61-68. https://doi.org/10.21147/j.issn.1000-9604.2021.01.07 |
| [14] | Galizia, G., Lieto, E., De Vita, F., Castellano, P., Ferraraccio, F., Zamboli, A., Mabilia, A., Auricchio, A., De Sena, G., De Stefano, L., Cardella, F., Barbarisi, A. and Orditura, M. (2015) Modified versus Standard D2 Lymphadenectomy in Total Gastrectomy for Nonjunctional Gastric Carcinoma with Lymph Node Metastasis. Surgery, 157, 285-296. https://doi.org/10.1016/j.surg.2014.09.012 |
| [15] | Yang, K., Chen, H.N., Liu, K., Zhang, W.H., Chen, X.Z., Chen, X.L., Zhou, Z.G. and Hu, J.K. (2016) The Survival Benefit and Safety of No. 12a Lymphadenectomy for Gastric Cancer Patients with Distal or Total Gastrectomy. Oncotarget, 7, 18750-18762. https://doi.org/10.18632/oncotarget.7930 |
| [16] | Cai, S.R., Chen, J.H., Chen, C.Q., Wu, K.M., Zhang, X.H., Song, W. and He, Y.L. (2015) Survival of Proper Hepatic Artery Lymph Node Metastasis in Patients with Gastric Cancer: Implications for D2 Lymphadenectomy. PLOS ONE, 10, e0118953. https://doi.org/10.1371/journal.pone.0118953 |
| [17] | Motoori, M., Kurokawa, Y., Takeuchi, H., et al. (2022) Risk Factors for Para-Aortic Lymph Node Metastasis in Esophagogastric Junction Cancer: Results from a Prospective Nationwide Multicenter Study. Annals of Surgical Oncology, 29, 5649-5654. https://doi.org/10.1245/s10434-022-11792-x |
| [18] | Sasako, M., Sano, T., Yamamoto, S., Sairenji, M., Arai, K., Kinoshita, T., Nashimoto, A., Hiratsuka, M. and Japan Clinical Oncology Group (JCOG9502) (2006) Left Thoracoabdominal Approach versus Abdominal-Transhiatal Approach for Gastric Cancer of the Cardia or Subcardia: A Randomised Controlled Trial. The Lancet Oncology, 7, 644-651. https://doi.org/10.1016/S1470-2045(06)70766-5 |
| [19] | Kurokawa, Y., Sasako, M., Sano, T., Yoshikawa, T., Iwasaki, Y., Nashimoto, A., Ito, S., Kurita, A., Mizusawa, J., Nakamura, K. and Japan Clinical Oncology Group (JCOG9502) (2015) Ten-Year Follow-Up Results of a Randomized Clinical Trial Comparing Left Thoracoabdominal and Abdominal Transhiatal Approaches to Total Gastrectomy for Adenocarcinoma of the Oesophagogastric Junction or Gastric Cardia. British Journal of Surgery, 102, 341-348. https://doi.org/10.1002/bjs.9764 |
| [20] | Shiraishi, O., Yasuda, T., Kato, H., et al. (2020) Risk Factors and Prognostic Impact of Mediastinal Lymph Node Metastases in Patients with Esophagogastric Junction Cancer. Annals of Surgical Oncology, 27, 4433-4440. https://doi.org/10.1245/s10434-020-08579-3 |
| [21] | Suh, Y.S., Lee, K.G., Oh, S.Y., et al. (2017) Recurrence Pattern and Lymph Node Metastasis of Adenocarcinoma at the Esophagogastric Junction. Annals of Surgical Oncology, 24, 3631-3639. https://doi.org/10.1245/s10434-017-6011-3 |
| [22] | Kurokawa, Y., Hiki, N., Yoshikawa, T., et al. (2015) Mediastinal Lymph Node Metastasis and Recurrence in Adenocarcinoma of the Esophagogastric Junction. Surgery, 157, 551-555. https://doi.org/10.1016/j.surg.2014.08.099 |
| [23] | Mine, S., Watanabe, M., Kumagai, K., Okamura, A., Yuda, M., Hayami, M., Yamashita, K., Imamura, Y. and Ishizuka, N. (2019) Comparison of Mediastinal Lymph Node Metastases from Adenocarcinoma of the Esophagogastric Junction versus Lower Esophageal Squamous Cell Carcinoma with Involvement of the Esophagogastric Junction. Diseases of the Esophagus, 32, doz002. https://doi.org/10.1093/dote/doz002 |
| [24] | Rüdiger Siewert, J., Feith, M., Werner, M. and Stein, H.J. (2000) Adenocarcinoma of the Esophagogastric Junction: Results of Surgical Therapy Based on Anatomical/Topographic Classification in 1002 Consecutive Patients. Annals of Surgery, 232, 353-361. https://doi.org/10.1097/00000658-200009000-00007 |
| [25] | Hosoda, K., Yamashita, K., Katada, N., Moriya, H., Mieno, H., Sakuramoto, S., Kikuchi, S. and Watanabe, M. (2015) Impact of Lower Mediastinal Lymphadenectomy for the Treatment of Esophagogastric Junction Carcinoma. Anticancer Research, 35, 445-456. |
| [26] | Kakeji, Y., Yamamoto, M., Ito, S., et al. (2012) Lymph Node Metastasis from Cancer of the Esophagogastric Junction, and Determination of the Appropriate Nodal Dissection. Surgery Today, 42, 351-358. https://doi.org/10.1007/s00595-011-0114-4 |
| [27] | Yamashita, H., Seto, Y., Sano, T., et al. (2017) Results of a Nation-Wide Retrospective Study of Lymphadenectomy for Esophagogastric Junction Carcinoma. Gastric Cancer, 20, 69-83. https://doi.org/10.1007/s10120-016-0663-8 |
| [28] | Ding, B., Yong, J., Zhang, L., et al. (2022) Impact of Examined Lymph Node Number on Accurate Nodal Staging and Long-Term Survival of Resected Siewert Type II-III Adenocarcinoma of the Esophagogastric Junction: A Large Population-Based Study. Frontiers in Oncology, 12, Article 979338. https://doi.org/10.3389/fonc.2022.979338 |
| [29] | Japanese Gastric Cancer Association (2023) Japanese Gastric Cancer Treatment Guidelines 2021 (6th Edition). Gastric Cancer, 26, 1-25. https://doi.org/10.1007/s10120-022-01331-8 |
| [30] | Li, S., Ying, X., Shan, F., Jia, Y., Li, Z., Xue, K., Miao, R., Wang, Y., Bu, Z., Su, X., Li, Z. and Ji, J. (2022) Laparoscopic vs. Open Lower Mediastinal Lymphadenectomy for Siewert Type II/III Adenocarcinoma of Esophagogastric Junction: An Exploratory, Observational, Prospective, Thoracic Lymph Node Involvement in Adenocarcinoma of IDEAL Stage 2b Cohort Study (CLASS-10 Study). Chinese Journal of Cancer Research, 34, 406-414. https://doi.org/10.21147/j.issn.1000-9604.2022.04.08 |
| [31] | 李双喜, 李子禹. 食管胃结合部腺癌腹腔镜手术的下纵隔淋巴结清扫边界及质量控制[J]. 中华胃肠外科杂志, 2022, 25(2): 120-123. |
